Trade Summary

Yesterday, GUGGENHIME ANDREW, serving as PRESIDENT AND CFO at Vaxcyte, Inc. (PCVX), sold 10,000 shares at $53.00 per share, for a total transaction value of $530,000.00. Following this transaction, GUGGENHIME ANDREW now holds 104,395 shares of PCVX.

This sale represents a 8.74% decrease in GUGGENHIME ANDREW's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 18, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 19, 2026 (accepted Jun 18, 8:07 PM ET), 1 day after the trade was made.

Vaxcyte, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.